MOLBIO

Molbio Diagnostics Limited · NSE · INE869T01028 · 33 sessions on record

₹1,513.10▲ +204.20 · +15.6%from ₹1,308.90 the session before · 1 Oct 2026 close · NSE end of day

Open: ₹1,313.00
High: ₹1,564.30
Low: ₹1,312.10
Day's range: ₹25019% of the previous close
VWAP: ₹1,467.46close +3.1% from it
Volume, shares: 88 L2.32× the 20-session average
Turnover, ₹ crore: 1,300
Trades: 3.9 L23 shares per trade
Previous close: ₹1,308.90+204.20 to the close
Price band, next session: ₹1,361.80 – ₹1,664.4010% either side of the close · dynamic, widened in 5% steps when hit

Day range80% of the way up

₹1,312.10₹1,564.30

52-week range77% of the way up

₹926.35 17 Aug₹1,686.80 11 Sept

−10% from the high · +63% from the low

Futures and options

No derivatives listed on MOLBIO

Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up33 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it

33 sessions on file · from 17 Aug

MOLBIO close
Nifty 50, rebased

Session read · latest close: 1 Oct 2026
Close ₹ · day %: ₹1,513.10▲ +15.6% on the previous close
Against Nifty 50: Nifty −0.9%+16.5 pp difference on the day
Against the averages: above 2020-session ₹1,279.32 (+18%)
Volume: 2.32×the previous 20 sessions · 88 L shares
Extremes on the day: none

Quarterly results

consolidated · latest filed 30 Jun, 05:30 am IST · NSE filings

Revenue ₹408 cr; profit ₹53 cr in the Jun 2026 quarter, consolidated.

Last 1 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session

Quarterly results of MOLBIO on the consolidated basis with the market's move on the first session after each filing
Quarter	Revenue ₹ cr	Revenue YoY	Profit ₹ cr	Profit YoY	EPS ₹	Market on the day
Jun 2026filed 30 Jun	₹408 cr	—	₹53 cr	—	5.21	—not reached

Fundamentals

consolidated · filings to Jun 2026 · close ₹1,513.10 on 1 Oct

market cap ₹17,000 cr.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing

Market cap: ₹17,000 cron 1 Oct · free float ₹10,000 cr
Price to earnings: —fewer than four consecutive quarters filed
Trailing EPS: —fewer than four consecutive quarters filed
Price to book: —no balance sheet filed yet
Book value a share: —no equity line in the filing
Debt to equity: —no equity line in the filing
Return on equity: —needs two filed balance sheets
Dividend yield: —no dividend with an ex-date in 365 days
Face value: ₹1a share
Shares outstanding: 12 cron 1 Oct

Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated

Revenue, trailing 12 months: —fewer than four consecutive quarters filed
Revenue growth, 12 months: —needs eight consecutive quarters filed
Revenue 3-year CAGR: —needs twelve consecutive quarters filed
Profit, trailing 12 months: —fewer than four consecutive quarters filed
Profit growth, 12 months: —needs eight consecutive quarters filed
Profit 3-year CAGR: —needs twelve consecutive quarters filed

PeersBSE sub-group Medical Equipment & Supplies · F&O stocks with filings on record · industry P/E needs two stocks with trailing profit and a market cap

Stocks in the BSE sub-group Medical Equipment & Supplies with market cap, price to earnings and price to book
Stock	Market cap ₹	P/E	P/B	Close ₹
MOLBIOMolbio Diagnostics Limited	17,000 cron 1 Oct	—	—	₹1,513.10
POLYMEDPoly Medicure Limited	17,000 cron 1 Oct	—	5.3	₹1,638.10
FISCHERFischer Medical Ventures Limited	2,200 cron 1 Oct	—	5.7	₹33.45
TARSONSTarsons Products Limited	1,800 cron 1 Oct	—	2.8	₹329.40
LAXMIDENTLLaxmi Dental Limited	1,100 cron 1 Oct	—	4.4	₹193.85
FABTECHFabtech Technologies Limited	630 cron 1 Oct	—	1.5	₹142.00
GKBGKB Ophthalmics Limited	32 cron 1 Oct	—	—	₹64.35
NURECANureca Limited	—	—	—	—

Shareholding

quarter to 14 Aug · none pledged · NSE filings

Promoters hold 41.3%, foreign portfolio investors 1.5%, mutual funds 2.3% and insurance companies 0.6%, as filed for the quarter to 14 Aug.

41.3%13.6%29.4%11.4%

By category, last 1 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file

Shareholding of MOLBIO by category over the last 1 quarters with the change against the previous quarter
Category	14 Aug
Promoters	41.29
Foreign portfolio investors	1.51
Mutual funds	2.25
Insurance companies	0.56
Banks and financial institutions	13.57
Individual investors	29.39
Bodies corporate	0.76
Other foreign holders	10.35
Others	0.33

Corporate actions

NSE and BSE records

No corporate action on record for MOLBIO yet.

Price history

33 sessions on record · to 1 Oct · NSE end of day

MOLBIO is +36.6% over 20 sessions against Nifty's −6.2%, 10% below its 52-week high, realised volatility 110% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions

Returns of the stock and Nifty 50 over six windows, longest first
Window	From ₹	MOLBIO %	Nifty 50 %	Difference pp
20 sessionssince 2 Sept	₹1,107.77	▲ +37%	▼ −6.2%	+43
5 sessionssince 24 Sept	₹1,246.17	▲ +21%	▼ −2.8%	+24
1 sessionsince 30 Sept	₹1,308.91	▲ +16%	▼ −0.88%	+16

Averages of the closeclose against each average

5-session average: ₹1,312.22close +15% from it
20-session average: ₹1,279.32close +18% from it

Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average

Average true range, 14: ₹1208.1% of the close
Average day's range, 20: ₹1409.0% of the close
Volume against 20 sessions: 2.32×88 L vs 41 L average

Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell

Realised volatility, 20: 110%≈ ±6.6% a session · moved more than that on 3 of 20

Up and down sessionscloses above and below the previous close

Last 20 sessions: 10 up · 10 downof 20
Best session, 250: ▲ +20%10 Sept
Worst session, 250: ▼ −7.6%27 Aug

Molbio Diagnostics Limited is in 1 NSE index

Nifty IPO

0 bulletins on MOLBIO

The desk has not written about Molbio Diagnostics Limited yet. The tape carries every bulletin as it is published.

About Molbio Diagnostics Limited

exchange masters as of 18 Sept 2026 · classification by BSE

Company: Molbio Diagnostics Limited
Exchange: NSE · BSE 544866, group B
Listed on NSE: 17 Aug 2026
Classification: Healthcare › Healthcare Equipment & Supplies › Medical Equipment & Supplies
Index: BSE IPO
Face value: ₹1 a share
ISIN: INE869T01028
Sessions on record: 33
Price source: NSE UDiFF bhavcopy · end of day · delayed
Filings: NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed: 1 Oct, 09:58 pm IST
Bulletins: 0 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.